Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—D.D.C.: Federal court dismisses provider’s claims over Medicaid payment suspension
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Revocation of billing privileges upheld against pharmacy that failed to update status change
    • ANTI-KICKBACK PROHIBITION—E.D. Mich.: Acquittal motion denied in Medicare kickback scheme, court rejects vagueness challenge to AKS
    • CONTROLLED SUBSTANCES—FINAL RULES: Placement of 4-Chloromethcathinone in Schedule I
    • EXPERT INSIGHTS—Patients Over Profit Act: A federal inflection point on insurer-provider integration and what comes next
    • GENERAL HEALTH CARE NEWS—D. Or.: Fertility services provider obtains dismissal of consumer claims about website PHI collection and disclosure
    • MEDICAID PAYMENT—OIG REPORTS: Texas to address errors in ambulance provider supplemental payments through procedural improvements
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—FINAL RULES: Placement of 4-Chloromethcathinone in Schedule I, (Nov 17, 2025)

    By WK Editorial Staff

    The action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances.

    The Drug Enforcement Administration is placing 4-chloromethcathinone (4–CMC, 1-(4- chlorophenyl)-2-(me ...

    By WK Editorial Staff

    The action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances.

    The Drug Enforcement Administration is placing 4-chloromethcathinone (4–CMC, 1-(4- chlorophenyl)-2-(methylamino)propan1-one), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. The action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 4- chloromethcathinone (Final Rule, 90 Fed. Reg. 51102 (Nov. 17, 2025)).

    Dates. Effective date: December 17, 2025.

    FederalRegisterIssuances: FinalRules DMENews SafetyNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use